Poor Healthcare Policies and Infrastructure, But India’s Pharma Market Continues to Boom

News   Aug 21, 2012

 
Poor Healthcare Policies and Infrastructure, But India’s Pharma Market Continues to Boom
 
 
 

RELATED ARTICLES

BioGenes Establishes Scientific Advisory Board

News

BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, announces the establishment of a Scientific Advisory Board.

READ MORE

Uptake of Controlled Release Drug Delivery Technology Set to Increase?

News

The increasing access to healthcare facilities and the bolstering need for drugs to be used orally has been driving the consumption of generic drugs among people across the world, which, in turn, is fueling the need for controlled release technology for drug delivery to suffice the availability of drugs in small dosages.

READ MORE

Metabolomic Profiling Identifies Taurine as New MS Therapeutic

News

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE